About Ashish Life Science Private Limited
Data last updated: 19 December 2025
Ashish Life Science Private Limited is a private limited company based in Palghar, Maharashtra, India. It specialises in animal pharmaceuticals and healthcare, a part of the broader pharmaceuticals sector. Incorporated on 10 January 1992, the company has been in operation for over 34 years.
Registered with ROC Mumbai under CIN U24100MH1992PTC064810.
Capital: an authorised share capital of ₹5.36 Cr and a paid-up capital of ₹4.8 Cr. Formerly known as Bhagat Chem India Pvt Ltd. It is led by directors including Parimal Merchant and Rajkumar Harnathrai Agarwal.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Plot J – 137 Midc Tarapur, Palghar, Maharashtra, India – 401506.
As per the financials filed for FY 2025, the company reported a revenue of ₹214.76 Cr, a growth of 15% compared to the previous year.
The company has a workforce of approximately 246 employees as per the latest available data.
The company is associated with 1 brand - Ashish Life Science. As per MCA filings, the company has open charges of ₹101.48 Cr and satisfied charges of ₹53.94 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ashishlifescience.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressPlot J – 137 Midc Tarapur, Palghar, Maharashtra, India – 401506
-
IndustryPharma, Animal Pharmaceuticals & Healthcare
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Ashish Life Science Private Limited
Ashish Life Science Private Limited operates one associated brand: Ashish Life Science. These brands represent Ashish Life Science Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Veterinary products are manufactured in Mumbai, India. | ashishlifescience.com |
Competitors & Alternatives of Ashish Life Science Private Limited
Brands and companies operating in the same space as Ashish Life Science Private Limited include Vetio, Xinfa Pharmaceutical, Sentez Kimya.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Vetio
|
Contract manufacturing of veterinary medicines is provided by Vetio. | St. Louis, United States, United States | 2001 |
Xinfa Pharmaceutical
|
Offers contract-based manufacturing services for veterinary drugs and related solutions. | Dongying, China, China | 1998 |
Sentez Kimya
|
Supplies raw materials for human, veterinary, and agricultural pharmaceuticals. | - | 2006 |
Business Activity of Ashish Life Science Private Limited
Ashish Life Science Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Ashish Life Science Private Limited
Ashish Life Science Private Limited is audited by S R B C & CO LLP for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S R B C & CO LLP | blur-value | blur-value | blur-value |
Board of Directors of Ashish Life Science Private Limited
Ashish Life Science Private Limited is currently managed by 5 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Parimal Merchant
Also directs:
Orion Legacy Sucess Partners Llp, Hind Rectifiers Limited, Sunjewels Private Limited and 1 more
|
Director | 12 Aug 2019 | 6 Years 11 Months | Current |
|
Rajkumar Harnathrai Agarwal
Also directs:
Jai Hanuman Dyeing And Printing Mills Pvt Ltd
|
Director | 29 Jul 2013 | 12 Years 11 Months | Current |
| Bhavik Bhupendra Parekh | Company Secretary | 01 May 2022 | 4 Years 2 Months | Current |
| Raujesh Premsukh Agarrwal | Managing Director | 18 Jun 2005 | 21 Years 0 Months | Current |
| Chintan Natwar Kothari | Director | 24 Mar 2025 | 1 Years 3 Months | Current |
Financials of Ashish Life Science Private Limited FY 2024 filings available
Ashish Life Science Private Limited reported revenue of ₹214.76 Cr (up 15% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Ashish Life Science Private Limited
As of FY 2023, Ashish Life Science Private Limited's shareholding pattern shows 96.69% by promoters, 3.31% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Ashish Life Science Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jul 2025 | Others | ₹3.64 Cr | Open |
| 27 Mar 2025 | Hdfc Bank Limited | ₹4 Cr | Open |
| 03 Jan 2025 | Sidbi | ₹3 Cr | Open |
| 08 Nov 2023 | Sidbi | ₹8.33 Cr | Open |
| 07 Feb 2022 | Others | ₹7 Cr | Open |
Total charge records: 21 View all charges
Employees and EPFO Compliance at Ashish Life Science Private Limited
Ashish Life Science Private Limited has a workforce of 246 employees as of Feb 18, 2025.
Employee Count & EPFO Data of Ashish Life Science Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Ashish Life Science Private Limited
GSTIN & GST Filing Data of Ashish Life Science Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Ashish Life Science Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Ashish Life Science Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Ashish Life Science Private Limited
MSME Payment Delays by Ashish Life Science Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Ashish Life Science Private Limited
Subsidiaries & Group Companies of Ashish Life Science Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Ashish Life Science Private Limited with ownership details.
MCA Filings & Documents of Ashish Life Science Private Limited
MCA Filings & Documents of Ashish Life Science Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Ashish Life Science Private Limited
Recent News on Ashish Life Science Private Limited
Frequently Asked Questions about Ashish Life Science Private Limited
Ashish Life Science Private Limited is an active private limited company in the pharma sector based in Palghar, Maharashtra, India. It was incorporated on 10 January 1992 (34+ years old) and is registered under CIN U24100MH1992PTC064810. The company has 246 employees.
Ashish Life Science Private Limited reported revenue of ₹214.76 Cr for FY 2025 (up 15.00% YoY).
The current directors of Ashish Life Science Private Limited are:
The primary industry of Ashish Life Science Private Limited is pharma. The company specifically operates in animal pharmaceuticals and healthcare. The company is currently active in this sector.
Ashish Life Science Private Limited can be reached at the registered office: Plot J – 137 Midc Tarapur, Palghar, Maharashtra, India – 401506, or through the website ashishlifescience.com.
The authorised capital is ₹5.36 Cr, and the paid-up capital is ₹4.8 Cr.